Avistone
Real Estate · Colorado, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
400 Inverness Pkwy Ste 160, Englewood, C...Phone Number
(303) 625-7005Website
www.avistone.comRevenue
$7.1 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
4
2
2
1
1
About Avistone
Avistone specializes in commercial real estate investing, offering clients opportunities to grow and diversify their portfolios through multi-tenant industrial properties. The firm focuses on enhancing property values through strategic improvements and expert management in high-growth markets. With a proven track record and emphasis on reducing investment risk, Avistone targets assets below replacement cost and prioritizes a diverse tenant base to maintain steady income and economic resilience. Established in 2013, the company provides investors with attractive cash distributions and potential tax advantages.Explore more
Avistone Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Avistone your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Avistone
Check out if Avistone is spiking on competitors!
Click to see if Avistone had a recent Job posting/layoffs
Avistone, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Avistone has new funding data
Website visits: Recent activity has been detected on your website
Check if Avistone has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Avistone recently announced quarterly report
Product Launch: Get notified when Avistone launches new products
Recommended Actions
Reach out to Masked Content who joined Avistone as Masked Content
Find more new buyers
Compare Similar Companies to Avistone
Compare insights from companies similar to Avistone, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Avistone is experiencing very low activity levels compared to other companies in the Real Estate sector.
What does this means?
Avistone is drawing exceptional interest within the Real Estate industry, suggesting notable developments or strong market momentum, learn more about Avistone.
Avistone financials insights
Gather financial insights about Avistone, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$350K
Avistone Tech Stack
A closer look at the technologies used by Avistone
Most Recent Scoops
Facilities Relocation / Expansion
Avistone has purchased 334,279 square feet of space at Breckenridge Park in Tampa, Florida for $31,750,000.
Real Estate
Facilities Relocation / Expansion
Avistone has purchased 334,279 square feet of space at Breckenridge Park in Tampa, Florida for $31,750,000.
Real Estate
Funding
Avistone has received an SBA PPP loan for $350,000-1 million from Bank of America, supporting the retention of 21 jobs.
Funding
Avistone News & Media
Chinese cancer therapy developer Avistone raises $141m from Bain, others
IDG Capital and CMG-SDIC Capital jointly led the Series B round.Avistone Announces the First Approval of Vebreltinib for MET Exon 14 Skipping Non-Small Cell Lung Cancer Opening a New Chapter in MET-targeted Treatment of Lung Cancer
BEIJING--(BUSINESS WIRE)--Avistone Biotechnology Co. Ltd. (“Avistone” or “the Company”), an innovative biotechnology company focused on precision oncology therapeutics, announced that they received conditional approval from the National Medical Products Administration (NMPA) to commercialize Vebreltinib (also referred to as PLB1001, APL-101, Bozitinib, CBT-101) to treat patients with MET exon 14 skipping non-small cell lung cancer (NSCLC) in China. The conditional approval was based on resultsAvistone Announces Phase II Results for Vebreltinib, a c-Met Tyrosine Kinase Inhibitor (TKI) at the European Society for Clinical Oncology (ESMO) Congress
BEIJING--(BUSINESS WIRE)--Avistone Biotechnology Co., Ltd. (“Avistone” or “the Company”), a clinical-stage biotechnology company focused on precision oncology therapeutics, announced preliminary results of the Phase II KUNPENG study of Vebreltinib in Patients (Pts) with advanced Non-small cell lung cancer (NSCLC) Harboring MET (mesenchymal-epithelial transition factor) alterations (Poster# 1379P) at the European Society for Clinical Oncology (ESMO) Congress in Madrid, Spain. MET signaling is imAvistone Announces Preclinical Results for ANS014004, a Type II c-Met Tyrosine Kinase Inhibitor (TKI) at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
BEIJING, China--(BUSINESS WIRE)--Avistone Announces Preclinical Results for ANS014004, a Type II c-Met Tyrosine Kinase Inhibitor (TKI) at the AACR-NCI-EORTC International Conference
Read more news
Top Real Estate Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Avistone
Sign Up For FreeTo access detailed company insights
Avistone specializes in commercial real estate investing, offering clients opportunities to grow and diversify their portfolios through multi-tenant industrial properties. The firm focuses on enhancing property values through strategic improvements and expert management in high-growth markets. With a proven track record and emphasis on reducing inv... Read More
